Contact us to get started

Hope begins here.

If you're an HR or benefits professional seeking cancer resources for your employees, or a consultant looking to provide best-in-class cancer support for your clients, share a few details below. We’ll reach out to help your company get started.

If you’re an employee looking for your AccessHope benefit, call 800.423.3232 and select Option 1.

Telehealth best practices: How to best care for your patients when ...

05/20/21 - Authority Magazine

AccessHope’s CMO Dr. Todd Sachs recently spoke with Authority Magazine about his background in healthcare and lessons he has learned throughout his career. In the interview, he articulates the benefits of in-person visits while discussing the challenges of virtual visits for patients, and then based on his experience, shares ways physicians can make the most of remote healthcare, especially for those living with cancer.

Read more

Robert Stone: City of Hope aims to transform cancer care nationally ...

04/02/21 - The Cancer Letter

AccessHope offers a new model that remotely connects more people with cancer through their employer health benefits to world-class cancer support from the leading institutions City of Hope and Northwestern Medicine. By engaging these employees’ local healthcare providers into collaborative relationships, AccessHope is extending the reach of leading cancer expertise to elevate local cancer care, creating a system that increases patient access to potentially lifesaving support.

Read more

Supporting Your Employees Facing Cancer

02/03/21 - WorldatWork

AccessHope CEO Mark Stadler shares how employer demand is accelerating the need for innovative cancer support services, driven by the goals to spend healthcare dollars wisely and ensure the best possible outcomes and quality of life for employees navigating a cancer journey. 

Read more

Ruxolitinib for the Treatment of Steroid-Refractory Chronic ...

01/27/21 - JAMA Network Open

AccessHope’s Vice President and Executive Clinical Director Joseph Alvarnas, MD, published a study in JAMA Network Open highlighting the use of a new treatment for the potentially life-ending chronic graft-vs-host disease (cGVHD) resulting from allogeneic hematopoietic stem cell transplantation (HSCT).

Read more

Interview with Mark Stadler, CEO, AccessHope

12/24/20 - Employee Benefits & Wellness Excellence

AccessHope CEO Mark Stadler shares with’s Employee Benefits & Wellness Excellence. Mark highlights how AccessHope is supporting its employees during unprecedented times with programs that promote workplace wellness. 

Read more